712 related articles for article (PubMed ID: 19758907)
41. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application.
Sinning C; Lillpopp L; Appelbaum S; Ojeda F; Zeller T; Schnabel R; Lubos E; Jagodzinski A; Keller T; Munzel T; Bickel C; Blankenberg S
Clin Res Cardiol; 2013 Jul; 102(7):495-503. PubMed ID: 23519584
[TBL] [Abstract][Full Text] [Related]
42. CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.
Habib RH; Dimitrova KR; Badour SA; Yammine MB; El-Hage-Sleiman AK; Hoffman DM; Geller CM; Schwann TA; Tranbaugh RF
J Am Coll Cardiol; 2015 Sep; 66(13):1417-27. PubMed ID: 26403338
[TBL] [Abstract][Full Text] [Related]
43. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
[TBL] [Abstract][Full Text] [Related]
44. Has the SYNTAX Score Become Obsolete?
Morice MC
J Am Coll Cardiol; 2018 Sep; 72(12):1330-1331. PubMed ID: 30213323
[No Abstract] [Full Text] [Related]
45. A more meaningful scoring system for determining the severity of coronary heart disease.
Gensini GG
Am J Cardiol; 1983 Feb; 51(3):606. PubMed ID: 6823874
[No Abstract] [Full Text] [Related]
46. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.
Généreux P; Palmerini T; Caixeta A; Rosner G; Green P; Dressler O; Xu K; Parise H; Mehran R; Serruys PW; Stone GW
J Am Coll Cardiol; 2012 Jun; 59(24):2165-74. PubMed ID: 22483327
[TBL] [Abstract][Full Text] [Related]
47. Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.
Campos CM; Stanetic BM; Farooq V; Walsh S; Ishibashi Y; Onuma Y; Garcia-Garcia HM; Escaned J; Banning A; Serruys PW;
Catheter Cardiovasc Interv; 2015 Nov; 86(6):E229-38. PubMed ID: 25946686
[TBL] [Abstract][Full Text] [Related]
48. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
[TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
De Luca G; Schaffer A; Verdoia M; Suryapranata H
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
[TBL] [Abstract][Full Text] [Related]
50. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
[TBL] [Abstract][Full Text] [Related]
51. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.
Capodanno D; Caggegi A; Miano M; Cincotta G; Dipasqua F; Giacchi G; Capranzano P; Ussia G; Di Salvo ME; La Manna A; Tamburino C
JACC Cardiovasc Interv; 2011 Mar; 4(3):287-97. PubMed ID: 21435606
[TBL] [Abstract][Full Text] [Related]
52. Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation.
Takahashi K; Serruys PW; Fuster V; Farkouh ME; Spertus JA; Cohen DJ; Park SJ; Park DW; Ahn JM; Kappetein AP; Head SJ; Thuijs DJ; Onuma Y; Kent DM; Steyerberg EW; van Klaveren D;
Lancet; 2020 Oct; 396(10260):1399-1412. PubMed ID: 33038944
[TBL] [Abstract][Full Text] [Related]
53. Widening clinical applications of the SYNTAX Score.
Farooq V; Head SJ; Kappetein AP; Serruys PW
Heart; 2014 Feb; 100(4):276-87. PubMed ID: 23878176
[TBL] [Abstract][Full Text] [Related]
54. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.
Collet JP; Thiele H; Barbato E; Barthélémy O; Bauersachs J; Bhatt DL; Dendale P; Dorobantu M; Edvardsen T; Folliguet T; Gale CP; Gilard M; Jobs A; Jüni P; Lambrinou E; Lewis BS; Mehilli J; Meliga E; Merkely B; Mueller C; Roffi M; Rutten FH; Sibbing D; Siontis GCM;
Eur Heart J; 2021 Apr; 42(14):1289-1367. PubMed ID: 32860058
[No Abstract] [Full Text] [Related]
55. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
Palmerini T; Genereux P; Caixeta A; Cristea E; Lansky A; Mehran R; Dangas G; Lazar D; Sanchez R; Fahy M; Xu K; Stone GW
J Am Coll Cardiol; 2011 Jun; 57(24):2389-97. PubMed ID: 21658558
[TBL] [Abstract][Full Text] [Related]
56. Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
Ahn JM; Roh JH; Kim YH; Park DW; Yun SC; Lee PH; Chang M; Park HW; Lee SW; Lee CW; Park SW; Choo SJ; Chung C; Lee J; Lim DS; Rha SW; Lee SG; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ
J Am Coll Cardiol; 2015 May; 65(20):2198-206. PubMed ID: 25787197
[TBL] [Abstract][Full Text] [Related]
57. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.
TIMI Study Group
N Engl J Med; 1985 Apr; 312(14):932-6. PubMed ID: 4038784
[No Abstract] [Full Text] [Related]
58. Cardiovascular disease in Europe: epidemiological update 2016.
Townsend N; Wilson L; Bhatnagar P; Wickramasinghe K; Rayner M; Nichols M
Eur Heart J; 2016 Nov; 37(42):3232-3245. PubMed ID: 27523477
[No Abstract] [Full Text] [Related]
59. SYNTAX Score and Outcomes of Coronary Revascularization in Diabetic Patients.
Kundu A; Sardar P; O'Day K; Chatterjee S; Owan T; Dawn Abbott J
Curr Cardiol Rep; 2018 Mar; 20(5):28. PubMed ID: 29572680
[TBL] [Abstract][Full Text] [Related]
60. Impact of Coronary Artery Disease Severity Assessed With the SYNTAX Score on Outcomes Following Transcatheter Aortic Valve Replacement.
Paradis JM; White JM; Généreux P; Urena M; Doshi D; Nazif T; Hahn R; George I; Khalique O; Harjai K; Lasalle L; Labbé BM; DeLarochellière R; Doyle D; Dumont É; Mohammadi S; Leon MB; Rodés-Cabau J; Kodali S
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
